0001209191-21-032740.txt : 20210514 0001209191-21-032740.hdr.sgml : 20210514 20210514163304 ACCESSION NUMBER: 0001209191-21-032740 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210512 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jakobovits Aya CENTRAL INDEX KEY: 0001823901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 21925232 MAIL ADDRESS: STREET 1: 3135 HUTTON DRIVE CITY: BEVERLY HILLS STATE: CA ZIP: 90210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-12 0 0001720580 Adicet Bio, Inc. ACET 0001823901 Jakobovits Aya C/O ADICET BIO, INC. 500 BOYLSTON STREET, 13TH FLOOR BOSTON MA 02116 1 0 0 0 Common Stock 2021-05-12 4 S 0 5000 13.2256 D 221807 I See Footnote Common Stock 2021-05-12 4 S 0 5000 13.2409 D 221806 I See Footnote Common Stock 329199 I See Footnote Common Stock 135799 I See Footnote These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.97 to $13.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The Reporting Person previously transferred 149,307 shares and 149,306 shares from the trust described in footnote (7) to the trusts described in footnotes (4) and (6), respectively. Shares held in a trust of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits child is the beneficiary. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.05 to $13.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Shares held in a trust of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits child is the beneficiary. Shares held in a grantor retained annuity trust ("GRAT") of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary. Shares held in a GRAT of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary. /s/ Nick Harvey, Attorney-in-Fact for Aya Jakobovits 2021-05-14